Get my own profile
Public access
View all23 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Gary GilmourCOMPASS PathwaysVerified email at compasspathways.com
- Andrew P McCarthyUniversity of SurreyVerified email at surrey.ac.uk
- Jonathan T. BrownUniversity of ExeterVerified email at exeter.ac.uk
- andrew randallProfessor of Applied Neurophysiology, University of ExeterVerified email at exeter.ac.uk
- Thomas RidlerLecturer in Neuroscience, University of ExeterVerified email at exeter.ac.uk
- Matt JonesUniversity of BristolVerified email at bristol.ac.uk
- Michael O'NeillHead of Molecular Pathology, Eli Lilly & Co. Ltd.Verified email at lilly.com
- Johanna JacksonVerified email at imperial.ac.uk
- Neil HardinghamCardiff UniversityVerified email at Cardiff.ac.uk
- Kevin FoxCardiff UniversityVerified email at cardiff.ac.uk
- Leonor Teles-Grilo RuivoEuropean Molecular Biology OrganizationVerified email at embo.org
- Michael ConwayEli LillyVerified email at network.lilly.com
- Jack MellorUniversity of BristolVerified email at bristol.ac.uk
- Ullrich BartschUniversity of SurreyVerified email at surrey.ac.uk
- Francois GastambideH. Lundbeck A/SVerified email at Lundbeck.com
- Marc GoodfellowUniversity of ExeterVerified email at exeter.ac.uk
- Jennifer FrancoisVertex pharmaceuticalsVerified email at vrtx.com
- James MonnVP Discovery Chemistry, Karuna TherapeuticsVerified email at karunatx.com
- Paul L. OrnsteinApollo Drug Discovery Consulting, LLCVerified email at apolloddc.com
- Eleftheria PervolarakiUniversity of LeedsVerified email at leeds.ac.uk